Propanc Biopharma, Inc. Common Stock (PPCB) is a publicly traded the market company. As of July 7, 2026, PPCB trades at $1.78 with a market cap of $4.03M and a P/E ratio of 0.00. PPCB moved -7.98% today. Year to date, PPCB is -87.03%; over the trailing twelve months it is -99.06%. Its 52-week range spans $1.30 to $600.00. Rallies surfaces PPCB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $1.78 |
| Market Cap | $4.03M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $600.00 |
| 52-Week Low | $1.30 |
| Volume | 4.30M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
PPCB analyst coverage data. Average price target: $0.00.